Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention.
Vaccination is one of the greatest achievements in public health of the 20th century. However, the success of vaccine uptake and adherence to immunization guidelines seen in pediatric populations has not been observed among adult Canadians. As a result of the disparity in susceptibility to vaccine-preventable disease, there has been an increasing shift of vaccine-preventable childhood diseases into adult populations. Accordingly, morbidity and mortality due to vaccine-preventable illnesses now occur disproportionately in adults. All Canadians, irrespective of age, should have immunity to measles, mumps, rubella, tetanus, diphtheria, pertussis and varicella. All adult Canadians with significant medical comorbidities or those older than 65 years of age should receive the pneumococcal polysaccharide vaccine and yearly trivalent inactivate influenza vaccines. The present review summarizes the burden of illness of these vaccine-preventable diseases in the Canadian adult population and reviews the current immunization recommendations. Vaccination of all Canadians to these common agents remains a vital tool to decrease individual morbidity and mortality and reduce the overall burden of preventable disease in Canada.
Parkins
Michael D
MD
Department of Medicine, University of Calgary, Calgary, Alberta;
McNeil
Shelly A
SA
Laupland
Kevin B
KB
MMWR Morb Mortal Wkly Rep. 1984 Jul 27;33(29):421-2, 427-30
6429514
Can Commun Dis Rep. 2008 Jul;34(ACS-3):1-46
18802991
Can J Public Health. 1999 May-Jun;90(3):160-3
10401164
JAMA. 2003 Jan 8;289(2):179-86
12517228
Vaccine. 2008 Mar 10;26(11):1432-7
18272261
J Infect Dis. 2000 Jul;182(1):174-9
10882595
AIDS Rev. 2007 Jul-Sep;9(3):173-87
17982942
MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60
18685555
Clin Infect Dis. 2001 Jun 15;32(12):1691-7
11360208
Epidemiol Infect. 2008 May;136(5):604-20
17612417
Br Med J. 1978 Dec 2;2(6151):1523-4
365288
BMJ. 2005 May 14;330(7500):1119-20
15891227
Lancet. 2006 Oct 14;368(9544):1365-76
17046469
Ann Intern Med. 1950 Jun;32(6):1075-86
15419601
Am J Prev Med. 2003 Aug;25(2):144-50
12880883
Can J Public Health. 2007 Sep-Oct;98(5):417-21
17985687
Lancet. 2005 Oct 1;366(9492):1165-74
16198765
Pediatr Infect Dis J. 2007 Apr;26(4):293-9
17414390
Cleve Clin J Med. 2007 Jan;74(1):13-5
17373343
Vaccine. 2007 Jan 26;25(7):1304-9
17055128
J Infect Dis. 1988 Jul;158(1):132-7
2839577
Chest. 2008 Mar;133(3):767-74
17890468
Am J Prev Med. 2007 Mar;32(3):177-185
17296469
Vaccine. 2002 May 22;20(17-18):2166-73
12009269
N Engl J Med. 1991 Nov 21;325(21):1453-60
1944423
Arch Intern Med. 1994 Dec 12-26;154(23):2666-77
7993150
Clin Infect Dis. 2007 Aug 15;45(4):459-66
17638194
Lancet. 2003 Mar 1;361(9359):763-73
12620751
Cleve Clin J Med. 2007 Jan;74(1):42-4, 47-8
17373346
J Infect Dis. 1992 Mar;165(3):553-6
1347058
J Clin Microbiol. 2006 May;44(5):1625-9
16672385
J Infect Dis. 2000 Aug;182(2):383-90
10915066
MMWR Morb Mortal Wkly Rep. 2005 Apr 22;52(54):1-85
15889005
J Med Virol. 2003;70 Suppl 1:S15-9
12627481
CMAJ. 1997 Apr 1;156(7):985-90
9099166
Lancet. 1996 Jun 22;347(9017):1739-44
8656909
Vaccine. 2002 Jun 7;20(19-20):2500-7
12057605
JAMA. 1994 Dec 7;272(21):1661-5
7966893
Can Commun Dis Rep. 2008 Sep;34(ACS-5):1-12
18856005
J Infect Dis. 2000 Feb;181 Suppl 1:S116-20
10657202
MMWR Recomm Rep. 1997 Apr 4;46(RR-8):1-24
9132580
Cochrane Database Syst Rev. 2007 Apr 18;(2):CD001269
17443504
Med Decis Making. 2003 Jan-Feb;23(1):76-82
12583457
J Pediatr. 1968 Apr;72(4):461-6
4869563
N Engl J Med. 1967 Feb 2;276(5):252-8
6016061
Clin Infect Dis. 2007 Jun 15;44(12):1529-31
17516393
J Am Geriatr Soc. 2004 Jan;52(1):25-30
14687311
J Infect Dis. 2004 May 1;189 Suppl 1:S4-16
15106083
Vaccine. 2008 Jan 24;26(4):494-501
18155326
J Med Virol. 2003;70 Suppl 1:S31-7
12627484
Emerg Infect Dis. 2006 Apr;12(4):709-10
16715588
MMWR Morb Mortal Wkly Rep. 1999 Apr 2;48(12):241-3
10220250
Clin Infect Dis. 2007 Jun 15;44(12):1532-5
17516394
Epidemiol Infect. 2002 Dec;129(3):599-606
12558344
J Infect Dis. 1998 Aug;178(2):431-40
9697723
Rev Epidemiol Sante Publique. 1998 Mar;46(2):100-7
9592852
N Engl J Med. 2006 Dec 14;355(24):2513-22
17167134
N Engl J Med. 2005 Jun 2;352(22):2271-84
15930418
Swiss Med Wkly. 2005 Apr 30;135(17-18):252-5
15965827
Can Commun Dis Rep. 2004 Feb 1;30:1-26
14964716
Braz J Med Biol Res. 2004 Jan;37(1):151-8
14689057
Vaccine. 2004 Dec 2;23(3):353-61
15530680
N Engl J Med. 2003 May 1;348(18):1737-46
12724479
CMAJ. 2006 Aug 29;175(5):483-8
16940266
J Infect Dis. 2004 May 1;189 Suppl 1:S236-42
15106117
J Infect Dis. 1996 Nov;174(5):986-93
8896499
JAMA. 2004 Sep 15;292(11):1333-40
15367555
Ann Intern Med. 1988 May;108(5):653-7
3358567
Aust Fam Physician. 2007 Jun;36(6):440-2, 444
17565403
Arch Intern Med. 2005 Feb 14;165(3):274-80
15710789
JAMA. 2007 Nov 14;298(18):2155-63
18000199
JAMA. 1993 Oct 20;270(15):1826-31
8411526
MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37
17167397
Nature. 1985 Nov 28-Dec 4;318(6044):323-9
3906406
Health Rep. 2006 May;17(2):43-8
16716035
J Infect Dis. 1995 Apr;171(4):885-9
7706815
Epidemiol Infect. 2000 Dec;125(3):651-69
11218215
J Fam Pract. 2000 Sep;49(9 Suppl):S51-63; quiz S64
11032193
Ann Intern Med. 1988 Apr;108(4):616-25
2964806
Clin Infect Dis. 2002 Mar 15;34(6):774-9
11830801
J Infect Dis. 1994 Jan;169(1):77-82
8277201
Can Commun Dis Rep. 2003 Sep 1;29:1-9
14526692
Vaccine. 2004 Mar 29;22(11-12):1362-71
15063558
Euro Surveill. 2005 May 19;10(5):E050519.1
16766825
Cochrane Database Syst Rev. 2004;(3):CD001269
15266445
J Am Acad Dermatol. 2007 Dec;57(6 Suppl):S136-42
18021865
Clin Microbiol Rev. 2003 Jul;16(3):357-64
12857772
J Infect Dis. 1990 Apr;161(4):728-35
2319166
J Am Acad Dermatol. 2007 Dec;57(6 Suppl):S130-5
18021864
Vaccine. 2005 Jul 1;23(31):4070-4
15950329
Can Commun Dis Rep. 2007 Aug 1;33(ACS-8):1-10
17847161